ARTICLE | Clinical News
Isoniazide: Phase IIa started
January 23, 2012 8:00 AM UTC
Bridge Bioresearch began a double-blind, placebo-controlled, U.K. Phase IIa trial to evaluate thrice-daily oral isoniazide for 12 weeks in about 60 patients with diabetic foot ulcers. ...